(Q36299994)

English

Safety of obesity drugs

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

Safety of obesity drugs (English)

1 reference

Europe PubMed Central

13 August 2017

1 reference

based on heuristic

inferred from title

Frank L Greenway

1

object named as

Frank L Greenway

1 reference

Europe PubMed Central

13 August 2017

author name string

Mary K Caruso

2

1 reference

Europe PubMed Central

13 August 2017

language of work or name

0 references

publication date

1 November 2005

1 reference

Europe PubMed Central

13 August 2017

Expert Opinion on Drug Safety

1 reference

Europe PubMed Central

13 August 2017

4

1 reference

Europe PubMed Central

13 August 2017

6

1 reference

Europe PubMed Central

13 August 2017

1083-1095

1 reference

Europe PubMed Central

13 August 2017

Increased expression in adipocytes of ob RNA in mice with lesions of the hypothalamus and with mutations at the db locus

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Weight-reducing effects of the plasma protein encoded by the obese gene

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Psychosocial origins of obesity stigma: toward changing a powerful and pervasive bias

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Echocardiographic characterization of the reversible cardiomyopathy of hypothyroidism

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Hyperthyroid heart disease

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma.

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Effects of TSH-suppressive therapy on cardiac morphology and function: beneficial effects of the addition of beta-blockade on diastolic dysfunction.

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Dinitrophenol and bioenergetics: an historical perspective

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

ACTIONS AND USES OF DINITROPHENOL

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

USE OF DINITROPHENOL IN OBESITY AND RELATED CONDITIONS

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

DINITROPHENOL AND DESICCATED THYROID IN THE TREATMENT OF OBESITY

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Use of Dinitrophenol in Nutritional Disorders : A Critical Survey of Clinical Results

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Mitochondrial uncoupling as a target for drug development for the treatment of obesity

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Overeating and obesity from damage to a noradrenergic system in the brain.

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

(+)-Amphetamine binding to rat hypothalamus: relation to anorexic potency for phenylethylamines.

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Glucose regulates [3H](+)-amphetamine binding and Na+K+ ATPase activity in the hypothalamus: a proposed mechanism for the glucostatic control of feeding and satiety

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Amphetamine induces dopamine efflux through a dopamine transporter channel.

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Weight Reduction Pills

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

The initiation of ventricular tachycardia and fibrillation by procaine in the isolated-perfused rabbit heart.

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Aminorex (Menocil) and amphetamine: acute and chronic effects on pulmonary and systemic haemodynamics in the calf

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Haemodynamic effects of oral aminorex and amphetamine in unanaesthetized beagle dogs

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Aminorex to fen/phen: an epidemic foretold

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Phenylpropanolamine and the risk of hemorrhagic stroke

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Comparison of continuous and intermittent anorectic therapy in obesity.

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Recreational use of aminorex and pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Long-term weight control: the National Heart, Lung, and Blood Institute funded multimodal intervention study

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Valvular heart disease associated with fenfluramine-phentermine

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

A population-based study of appetite-suppressant drugs and the risk of cardiac-valve regurgitation

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Serial echocardiographic and clinical evaluation of valvular regurgitation before, during, and after treatment with fenfluramine or dexfenfluramine and mazindol or phentermine

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Echocardiographic improvement over time after cessation of use of fenfluramine and phentermine

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Double-blind, randomized, placebo-controlled clinical trials with non-prescription medications for the treatment of obesity.

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

The safety and efficacy of pharmaceutical and herbal caffeine and ephedrine use as a weight loss agent

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Efficacy and safety comparative evaluation of orlistat and sibutramine treatment in hypertensive obese patients

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Safety and efficacy of sibutramine in overweight Hispanic patients with hypertension

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Efficacy and safety of sibutramine in obese white and African American patients with hypertension: a 1-year, double-blind, placebo-controlled, multicenter trial

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

The management of hypertension in the overweight and obese patient: is weight reduction sufficient?

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

A benefit-risk assessment of sibutramine in the management of obesity

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Sibutramine lost and found

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Sibutramine produces dose-related weight loss

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract.

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

CB1 cannabinoid receptor-mediated modulation of food intake in mice

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Body mass, depressive symptoms and menopausal status: an examination of the "Jolly Fat" hypothesis

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.6.1083

21 January 2018

Identifiers

10.1517/14740338.4.6.1083

1 reference

Europe PubMed Central

13 August 2017

1 reference

Europe PubMed Central

13 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36299994&oldid=2066226054"